Roger Bonnert

Title: Roger Bonnert: Innovator in Therapeutic Compounds

Introduction

Roger Bonnert is a notable inventor based in Geneva, Switzerland. He has made significant contributions to the field of therapeutic compounds, particularly through his innovative work on Imidazo[1,2-a]pyridine compounds. His research and inventions have the potential to impact various therapeutic applications.

Latest Patents

Roger Bonnert holds 1 patent for his invention titled "Imidazo[1,2-a]pyridine compounds and their use in therapy." This patent relates to compounds of Formula (I) and explores their various therapeutic applications. His work in this area showcases his commitment to advancing medical science.

Career Highlights

Throughout his career, Roger has worked with several esteemed organizations. Notably, he has been associated with Imperial College Innovations Limited and Myricx Pharma Limited. His experience in these companies has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Roger has collaborated with talented individuals in his field, including Edward William Tate and Andrew Simon Bell. These partnerships have contributed to the development of his inventions and have fostered a collaborative environment for innovation.

Conclusion

In summary, Roger Bonnert is a distinguished inventor whose work on Imidazo[1,2-a]pyridine compounds has the potential to make a significant impact in therapeutic applications. His collaborations and career experiences further highlight his contributions to the field of innovation.